{"ticker": {"uuid": "368d8508-346b-4537-a836-ad138b12f514", "symbol": "STIM", "name": "Neuronetics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "What Does Jorey Chernett's Recent Buying Spree Signal for Neuronetics (STIM)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOUm52VjdBN1F5eFpycExKczdrdUpGNXFmb1NIT21sMFA1RDBUUkxwVHdfRFpOVTY4TXJfMGE2cGtObl9SOGh1RTEweV9lUUV0VUt4bk10TTRNQXBmSzU2NUphcVVSRloycHJXQ2RGQmNHd0JMUEJHWF8xazVoOWtrc0tIQWlrZzFrV2c1aGRUcVdBM20waGJBWE15LXBKczlDd0J1eXQwTlNZTl9qQlE?oc=5", "source_name": "Kavout | AI", "published_at": "2026-07-15T23:09:01+00:00", "published_display": "15 Jul 2026 23:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Buying: Jorey Chernett Acquires 35,000 Shares of Neuronetics Inc (STIM)", "summary": "Jorey Chernett, a 10% owner of Neuronetics Inc (STIM), purchased 35,000 shares on July 14, 2026, increasing his total holdings to 10,588,988 shares. This acquisition is part of a trend where Chernett has bought over 3.6 million shares in the past year with no sales. Neuronetics I", "url": "https://www.gurufocus.com/news/8960617/insider-buying-jorey-chernett-acquires-35000-shares-of-neuronetics-inc-stim", "source_name": "GuruFocus", "published_at": "2026-07-15T16:19:03", "published_display": "15 Jul 2026 16:19", "sentiment": "positive", "sentiment_pct": 72, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics (NASDAQ: STIM) major holder buys 35,000 common shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNN1o1MGZFelBTQVc2TEF6QUFjaGFHbEUxMFIxeHh3RVQ2cGtsM1pJOEN1M2oyWEtNdGNtUTRJWF9hLWVPR1BNNHB1akJBbGpPYVFiLTlneHpsWE5kUU54ZDFfOWdDa1lxdVlEWlcwWi16SWFrdm02SnJDRnRiU2E4RlFIb2k3cmFlVDVza0wyblpPQ2cyUVdsVENIZnRodEV6dWFOS3d5ZkZCVExqbHc?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T13:33:48+00:00", "published_display": "15 Jul 2026 13:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Neuronetics Inc For: 15 July By Investing.com", "summary": "This article from Investing.com announces the filing of Form 4 for Neuronetics Inc. on July 15. The brief piece includes the stock symbol STIM and notes a 3.95% increase for the company. It serves as a concise update on a regulatory filing for Neuronetics.", "url": "https://ca.investing.com/news/stock-market-news/form-4-neuronetics-inc-for-15-july-93CH-4735508", "source_name": "Investing.com Canada", "published_at": "2026-07-15T13:19:03", "published_display": "15 Jul 2026 13:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics: Jorey Chernett acquires $62,300 common stock", "summary": "Jorey Chernett, a 10% owner of Neuronetics, Inc. (NASDAQ:STIM), acquired 35,000 shares of common stock for $62,300 on July 14, 2026. This transaction increased his direct holdings to 10,588,988 shares. Despite a recent 15% stock return, InvestingPro analysis indicates the shares ", "url": "https://www.investing.com/news/insider-trading-news/neuronetics-jorey-chernett-acquires-62300-common-stock-93CH-4793564", "source_name": "Investing.com", "published_at": "2026-07-15T13:19:03", "published_display": "15 Jul 2026 13:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics (STIM) to Present at B. Riley Mind, Muscle & Vision Summit", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQX1RERE1LOFFuTXBoRWxMa2tPSGN2QTlIVFdJUEJUVzFIbGRzUEFsRHJzSGhad3g1UFN1TU0tR3NBSms3THIwRmV3eHItWmh3MG8xa3FNQ0V3SG5qQy1SallONXNvU2VCaGhNMVVBcFdnaUpoR3ZjYng3TXNCbVdvb1NvZHlsZ3ZjcFdkT2pCZmZYMDJ4Ty02cg?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:08:05+00:00", "published_display": "14 Jul 2026 18:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Neuronetics (STIM) EVP Cory Anderson reports PRSU awards tied to cash metrics", "summary": "Neuronetics' EVP & Gen. Manager, Greenbrook, Cory Anderson, filed an initial statement of beneficial ownership, revealing holdings of common stock and performance restricted stock units (PRSUs). These PRSUs, totaling up to 15,000 and 18,335 shares, vest between December 2026 and ", "url": "https://www.stocktitan.net/sec-filings/STIM/form-3-neuronetics-inc-initial-statement-of-beneficial-ownership-fe3a93f52626.html", "source_name": "Stock Titan", "published_at": "2026-07-13T20:41:55", "published_display": "13 Jul 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026", "summary": "Neuronetics, Inc. announced its management will participate in a panel discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026, in Boston. The panel, titled \"Commercializing the Next Wave of Novel Neuropsychiatric Drugs,\" will include Compass Pathways. Ne", "url": "https://www.manilatimes.net/2026/07/06/tmt-newswire/globenewswire/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026/2379046/amp", "source_name": "The Manila Times", "published_at": "2026-07-06T12:41:53", "published_display": "06 Jul 2026 12:41", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics to Participate at B. Riley Securities\u2019 Mind, Muscle & Vision Summit", "summary": "Neuronetics, Inc. will participate in the B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026, in Boston. The company will be part of a panel discussion focused on \"Commercializing the Next Wave of Novel Neuropsychiatric Drugs\" and will also hold one-on-one meeting", "url": "https://www.quiverquant.com/news/Neuronetics+to+Participate+at+B.+Riley+Securities%E2%80%99+Mind,+Muscle+&+Vision+Summit", "source_name": "Quiver Quantitative", "published_at": "2026-07-06T12:41:49", "published_display": "06 Jul 2026 12:41", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics joins neuropsychiatry panel at B. Riley investor summit", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNMkwwOTJfTDl5MlV5VjhpUnJYUExHOEFpd29RZHEyRnJEeUptLVBXb0ZpSUZkRndXVm14VWR1Q0ZJNTZaQVdWam9WeFR1UkF6eGMyLXlVSmxlZnd5ZGpZR2w5N2duZkZ2TkJfV2k1aGE3aVYzMDZJQnRQRExzVV90YmNqUno5LUtpamgyYjlCS1JPcmtvVnlTN19xcEh2OFEwV0U4aU9VM0otSXNWNzZCbEVXZ1Y?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics stock leans on its core therapy platform.", "summary": "Neuronetics (NASDAQ:STIM) stock continues to focus on its medical-device business, with investors looking at the company's NeuroStar therapy platform and its commercial rollout. The company's core product, NeuroStar Advanced Therapy, is a noninvasive treatment system for depressi", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/neuronetics-stock-leans-on-its-core-therapy-platform/69682101", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-03T17:39:17", "published_display": "03 Jul 2026 17:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STIM News | NEURONETICS INC (NASDAQ:STIM)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTFBWV0g0SDhSV1p5SHNzbmNZTUJuX0dBQVBDa2ZLNmowVUVXUk9QcEtqT1p4TGVzMEpKRjVpQzhSODRoSWR6SFliSGFqS0dhdTdrVEZsNExlRHl5MUE?oc=5", "source_name": "ChartMill", "published_at": "2026-07-03T00:06:54+00:00", "published_display": "03 Jul 2026 00:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics, Inc.(NasdaqGM: STIM) dropped from Russell 2000 Growth Benchmark", "summary": "Neuronetics, Inc. (NasdaqGM: STIM) has been removed from the Russell 2000 Growth Benchmark and several other Russell indices, including the Russell 2000, Russell 2500, Russell 3000, and Russell 3000E indices and their growth benchmarks. This change follows a series of recent lead", "url": "https://www.marketscreener.com/news/neuronetics-inc-nasdaqgm-stim-dropped-from-russell-2000-growth-benchmark-ce7f5fdcd981f624", "source_name": "marketscreener.com", "published_at": "2026-07-01T11:12:09", "published_display": "01 Jul 2026 11:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Neuronetics, Inc. \u2013 NASDAQ:STIM", "summary": "This page provides financial information for Neuronetics, Inc. (NASDAQ: STIM), specifically focusing on its forward price-to-sales ratio. It appears to be a financial data page from TradingView, offering an overview of the company's financials for investors and analysts. Despite ", "url": "https://www.tradingview.com/symbols/NASDAQ-STIM/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T20:10:58", "published_display": "28 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Neuronetics, Inc. \u2013 NASDAQ:STIM", "summary": "This article provides financial information for Neuronetics, Inc. (NASDAQ: STIM), specifically its enterprise value to EBITDA forward. It indicates data is sourced from ICE Data Services, FactSet, American Bankers Association, and Quartr for SEC filings.", "url": "https://www.tradingview.com/symbols/NASDAQ-STIM/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T18:39:43", "published_display": "26 Jun 2026 18:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics Inc (STIM) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "Neuronetics Inc (STIM) currently has a price momentum score of 6.93, ranking 131st in its industry, with its stock trading between resistance at $1.66 and support at $1.09, suggesting suitability for range-bound swing trading. Technical indicators show a mixed signal with 2 buy, ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-stim/technical", "source_name": "TradingKey", "published_at": "2026-06-26T17:10:44", "published_display": "26 Jun 2026 17:10", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics, Inc. Actuals & Estimates (NASDAQ:STIM)", "summary": "This article provides an overview of Neuronetics, Inc. (NASDAQ: STIM) stock, including its current price, market capitalization, volatility, and analyst forecasts. It also details financial data such as past earnings, revenue, net income, and upcoming earnings report dates. The c", "url": "https://www.tradingview.com/symbols/NASDAQ-STIM/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T16:39:32", "published_display": "26 Jun 2026 16:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Neuronetics, Inc. \u2013 NASDAQ:STIM", "summary": "This article provides financial information for Neuronetics, Inc. (NASDAQ: STIM), specifically its forward price-to-earnings ratio. It indicates that the market was closed at the time of publication and no trades were recorded. The content is presented within the context of Tradi", "url": "https://www.tradingview.com/symbols/NASDAQ-STIM/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T03:10:03", "published_display": "26 Jun 2026 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STIM Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for Neuronetics, Inc. (STIM) stock, based on analysis from three different analysts. It includes current stock performance metrics, historical price data, financial statements, and an earnings report schedule. The article also pro", "url": "https://www.tradingview.com/symbols/NASDAQ-STIM/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T00:08:58", "published_display": "26 Jun 2026 00:08", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 8K Neuronetics Inc For: 23 June By Investing.com", "summary": "This article announces that Neuronetics Inc. filed a Form 8K on June 23. The Form 8K is a crucial SEC filing that companies use to announce unscheduled material events or corporate changes that are important to shareholders and the SEC. Further details about the content of the fi", "url": "https://ng.investing.com/news/stock-market-news/form-8k-neuronetics-inc-for-23-june-93CH-2570907", "source_name": "Investing.com Nigeria", "published_at": "2026-06-24T15:40:51", "published_display": "24 Jun 2026 15:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cory Anderson named EVP, GM of Greenbrook at Neuronetics (NASDAQ: STIM)", "summary": "Neuronetics, Inc. has promoted Cory Anderson to Executive Vice President, General Manager of Greenbrook, effective July 1, 2026. Anderson, who previously served as Senior Vice President, Chief Technology Officer, will receive an annual base salary of $425,000 and a target discret", "url": "https://www.stocktitan.net/sec-filings/STIM/8-k-neuronetics-inc-reports-material-event-6b0ba4128523.html", "source_name": "Stock Titan", "published_at": "2026-06-23T20:10:13", "published_display": "23 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics Inc (STIM) Institutional Confidence", "summary": "The article reports on Neuronetics Inc's (STIM) institutional confidence score, which is currently 5.00, placing it 109th out of 203 in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion has increased by 11.24% quarter-over-quarter, reaching 6", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-stim/sentiment", "source_name": "TradingKey", "published_at": "2026-06-19T01:40:33", "published_display": "19 Jun 2026 01:40", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics Inc (STIM) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Neuronetics Inc (STIM) currently holds an earnings forecast score of 8.00, placing it 66th in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $7.00, with a consensus \"Buy\" rating based on 3 analysts. The company's expected revenue for th", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-stim/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T14:09:11", "published_display": "18 Jun 2026 14:09", "sentiment": "positive", "sentiment_pct": 76, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics Inc (STIM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for Neuronetics Inc (STIM) by business segments and regional contributions. The data, updated on April 6th, shows that Clinic revenue and Treatment sessions are the largest business segments, while the United States accounts for the vast ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-stim/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T05:40:10", "published_display": "18 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics Inc (STIM) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis for Neuronetics Inc (STIM), indicating its current valuation score is 8.49, ranking it 94 out of 204 in the Healthcare Equipment & Supplies industry. It highlights the company's P/E ratio of -2.24, noting its position relative to recent ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-stim/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-18T01:09:11", "published_display": "18 Jun 2026 01:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics Inc (STIM) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Neuronetics Inc (STIM), outlining its major shareholders and institutional holdings as of recent reporting periods. It identifies top shareholders such as Madryn Asset Management, LP, Chernett (Jorey), and Parian Ultreia LP, and c", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-stim/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T00:40:11", "published_display": "18 Jun 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics Inc (STIM) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Neuronetics Inc's (STIM) dividend and stock split history. It notes that no dividends have been distributed in the past five years and there is no data available for stock splits. The page also includes current stock performance metrics and ma", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-stim/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T00:40:11", "published_display": "18 Jun 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Madryn funds (NASDAQ: STIM) reallocate 72,500 Neuronetics RSU shares", "summary": "Madryn Asset Management's affiliated funds have reallocated 72,500 Neuronetics (NASDAQ: STIM) RSU shares. These internal transfers, reported in an SEC Form 4 filing, involved shares granted as director compensation to Avinash Amin and moved among Madryn Health Partners II, Madryn", "url": "https://www.stocktitan.net/sec-filings/STIM/form-4-neuronetics-inc-insider-trading-activity-b2042bc08b67.html", "source_name": "Stock Titan", "published_at": "2026-06-17T20:39:24", "published_display": "17 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics (NASDAQ: STIM) director reallocates 42,500 shares to Madryn funds", "summary": "Neuronetics (NASDAQ: STIM) director Avinash Amin reallocated 42,500 shares of common stock across three affiliated Madryn funds (Madryn Health Partners II, LP, Madryn Health Partners II (Cayman Master), LP, and Madryn Select Opportunities, LP) on June 15, 2026. These J-code trans", "url": "https://www.stocktitan.net/sec-filings/STIM/form-4-neuronetics-inc-insider-trading-activity-8e9bb69fc5aa.html", "source_name": "Stock Titan", "published_at": "2026-06-17T20:39:24", "published_display": "17 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "STIM (NASDAQ) affiliate files to sell 42,164 vested shares via Fidelity", "summary": "An affiliate of Neuronetics, Inc. (NASDAQ: STIM) has filed a Form 144 notice to sell 42,164 shares of common stock stemming from restricted stock vesting. The proposed transaction is intended for June 8, 2026, and lists Fidelity Brokerage Services LLC as the broker-dealer. The fi", "url": "https://www.stocktitan.net/sec-filings/STIM/144-neuronetics-inc-sec-filing-c41f32a0d015.html", "source_name": "Stock Titan", "published_at": "2026-06-08T22:38:42", "published_display": "08 Jun 2026 22:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics Appoints Robert Greene as Senior Vice President Sales", "summary": "Neuronetics, Inc. (NASDAQ: STIM) has announced the appointment of Robert Greene as Senior Vice President Sales, effective June 1, 2026. Greene brings extensive experience in commercial strategy and sales leadership within the healthcare and medical technology sectors. In connecti", "url": "https://www.manilatimes.net/2026/06/03/tmt-newswire/globenewswire/neuronetics-appoints-robert-greene-as-senior-vice-president-sales/2357331", "source_name": "The Manila Times", "published_at": "2026-06-03T07:40:31", "published_display": "03 Jun 2026 07:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics, Inc. Announces Appointment of Robert Greene to Senior Vice President Sales, Effective June 1, 2026", "summary": "Neuronetics, Inc. has announced the appointment of Robert Greene as its Senior Vice President Sales, effective June 1, 2026. Greene brings extensive experience in leading commercial strategy and sales organizations within the healthcare and medical technology sectors, including c", "url": "https://www.marketscreener.com/news/neuronetics-inc-announces-appointment-of-robert-greene-to-senior-vice-president-sales-effective-j-ce7f5ddfd88ff622", "source_name": "www.marketscreener.com", "published_at": "2026-06-03T06:40:55", "published_display": "03 Jun 2026 06:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New Neuronetics sales chief gets 200,000-share stock grant", "summary": "Neuronetics (NASDAQ: STIM) has appointed Robert Greene as its Senior Vice President of Sales, effective June 1, 2026. In connection with his hiring, Greene received an inducement grant of 200,000 restricted stock units (RSUs), vesting in four equal annual installments. This appoi", "url": "https://www.stocktitan.net/news/STIM/neuronetics-appoints-robert-greene-as-senior-vice-president-h9ikiqhbr4un.html", "source_name": "Stock Titan", "published_at": "2026-06-02T20:39:48", "published_display": "02 Jun 2026 20:39", "sentiment": "positive", "sentiment_pct": 69, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/neuronetics-highlights-continued-advancements-tms-123200467.html", "source_name": "GlobeNewswire", "published_at": "2026-06-02T12:32:00+00:00", "published_display": "02 Jun 2026 12:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STIM - Neuronetics Inc Stock Price and Quote", "summary": "", "url": "https://news.google.com/rss/articles/CBMiRkFVX3lxTE5UckMxYm11eENDaEIwZUpKME5vUlFZaTZOSXBLNnp3MWhnbXA5RXI1VHlzbEhRSTNRc1VrWG1ZN2gtNktFeEE?oc=5", "source_name": "Finviz", "published_at": "2026-05-27T09:08:06+00:00", "published_display": "27 May 2026 09:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/neuronetics-ant-neuro-announce-strategic-123200783.html", "source_name": "GlobeNewswire", "published_at": "2026-05-14T12:32:00+00:00", "published_display": "14 May 2026 12:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics Insider Bought Shares Worth $636,500, According to a Recent SEC Filing", "summary": "", "url": "https://finance.yahoo.com/news/neuronetics-insider-bought-shares-worth-123700257.html", "source_name": "MT Newswires", "published_at": "2026-05-13T12:37:00+00:00", "published_display": "13 May 2026 12:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics (STIM) Margin Compression Reinforces Bearish Clinic Mix Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/f14e3ff5-d0a2-334d-9b3d-981c4b206675/neuronetics-q1-earnings-call.html", "source_name": "MarketBeat", "published_at": "2026-05-05T21:07:06+00:00", "published_display": "05 May 2026 21:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/61767052-afa9-3de5-9860-759b289c09eb/neuronetics%2C-inc.-q1-2026.html", "source_name": "Moby", "published_at": "2026-05-05T20:55:23+00:00", "published_display": "05 May 2026 20:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics STIM Stock Jumps As Activist Pressure Meets Growth Tailwinds", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE9FVGlmRXpJc2E3VVNnU3VzdlRRZjRUWC1JcW00MWM4UThKZE94RG9KVGg4SWRpTnRpbjJEOGlYcHBFWlZUSTBKLWFmc3NuRW5RWTBTNDBVUTd3M2E3QlFYWDN4WWZibldzT1RINXpKVVFqSGN2TUJB?oc=5", "source_name": "StocksToTrade", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NEURONETICS ($STIM) Releases Q1 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxQUVVmMV9VTGl4eDRCclFYYUJ4cTdLM0pNd3BlRmhhN2Z1MDQ0T1BuajBsbGw3anpWSFZlcmxONDdLLWZfb1BIelpOMGFPN0tiX2FZU0VFeVZtNjZSMk5JcUlvUzhzZWtiS1pXeXdxQ2F6QkdIanhFZnFrWWMtU29RcUg4TFNWN1BwcEFXaw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQRmVsckdlQ09JYk9aZVNuaFF5VXV3QVBGRXpaOE42MmluMVRSQkc5NlJnMmxvblQtME5tbmpkNUkzeDh4OUZLUS1USXhUN0M3Z2JudXdINGFBWlVPWXBLTm41VDR6bWRCU0s5ckVEWkp6TWlwbk55RGpFUmFIaTFnam1fOEtmbVlnZzlZS2Jpc0VoQ1R6UUZxVExNQW9oVnRudXow?oc=5", "source_name": "Market source", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "How The Neuronetics (STIM) Investment Story Is Evolving With A Reset Price Target", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQd1ZsdVRXWVZtZEMwQ0JLcVlSX0xXRWVDSzlPTVgxeURmQXpLQXBCdTc5dmVwZ1g3MmliVkNVVS16RlhVTjI0UW13ZEhRSGk5QW5wbjd2TC1hTHRrcmotRGhCcHpodmZHSlFBVzF4UGJCTDFPYkx3LTdldnlpZ002bUFHVVBPdkNWM05qWGpLSFlZSnY2bE9zNDFqNlA4eERPbEg2dXp3WVA4aGM?oc=5", "source_name": "Market source", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New Neuronetics hires get stock awards that vest over up to 4 years", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPZDRnQnpubzhFZmV1ZWRhQVYzVGx0U3hpYlFmZUs3WGl2ZTJhLUVHWnZmaGRZQVJBZ2RaM0w5bXMxVFNSb3h0c3JkOHRiRS1WUHJaWDF1T25BVkRQclVkbUpMaF9LNU5COUpldjhnQWltVHhfZHpxeGx2NzRwbnZIZm1pQlllUFBYNW5YQjZ5SktCam02VDNfcmRuWW1EZEx3NldWaENPTGwyby02WVVnV2JwSWpyRTVPSnRXMXhJZw?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "How The Neuronetics (STIM) Investment Story Is Reset As Analysts Rework Valuation Assumptions", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOSnNHNkZmQVJ0YndJaUV5ekhqYzA1YmNqaFAyRTZiY1kxRXZXcVBxX1pZd2c5RXZJbUMtWFJKM2tBVzh5aThnRHlPdjdrUmtMN3RQandSaFZXc3lDQzJwMlJNZUw2TkZ0cUs0QVJJTU8tdTRaTGEwN29hWGxWb2JPc3VqMXh4ZUg3ZDZUUG1SZEhhaGxtdWRKM2VnZmQ1YmRmdW50OW5Ccw?oc=5", "source_name": "Market source", "published_at": "2026-04-18T07:00:00+00:00", "published_display": "18 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics says board is open to shareholder talks on valuation", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQWkdreUtQdTRVVkZrUTZicFZPRVBRc2dzMVFsdHhZUXJvLTVOYUhoYVIzR3A5cjJ5aENWNlF2aVhQRndCb2N3OTIyNy1oMmVHOVM3NkRreGRxZG5leGxuellVNHB1REZkai1qa2lwODNseWNoc3VlUDZNWUFCQ2ZNbGYtYzViRFRqcTIxa1NTN3NhWndfT1IwWUpMbEREZUJBTzdwYVE0YWJNRi1IOFE?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Neuronetics sticks with 2026 outlook as finance chief plans exit", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNeU0xcHhwdmZ4MkIwdWNRakJWOE5iTDNxeEJKOFRPMU5tZWdFcUtUM085TndvX3RZRXN3bE1WYmc1RGp6NzlrNl9lU3FnNF9PVTd2T3BZYS1sTEVkdkRlNGZoMDBzMmdsVW5keGp5UTNuXzVab1RtOXB3WUpHdUp6LU5tUzlhZWVXZmN3MEdINVFxTlh3Rmw3d3VZZjlsaTZaUmc?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-06T07:00:00+00:00", "published_display": "06 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Neuronetics (STIM) Story Is Shifting As Analysts Rework Valuation Assumptions", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNSE1PT3VSVTRHZTFQUV93NzhnaHdaSEdnRFJGZDVFeUdTQ3ZIYW1jYm91VU5zN2ktQlZTTm93YnBBaWFCSm52TFBaNzd6ZnRjQWxRRU4ySEI4VGNtek5obEpmOTBVclloRHNBcWNZcWVyOEMxOHAyeUVoRUZsYnVrMUZrNmpSaEpUdDlyOEMxUldxazA4WWpRVGEwLVIzUVR0V0NMOUlpa04?oc=5", "source_name": "Market source", "published_at": "2026-04-03T07:00:00+00:00", "published_display": "03 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Neuronetics: Highly Speculative, But Revenue Growth Could Drive The Stock Higher (STIM)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSGtJMHdPUjVtb1h2QlBscUdQaDJqR0QtM0J1VHF2Z0h4clhqcW4yM01GRk5weWdnRlhvenN3UDFtblVFTDlCWDNLQ0FiYXJDaXg4dHFVc1JSaGxqakxIek9LelNXSmg5ZTUtMHAybTdFMmhsR3c2MTc4eVhWOUNUV2ZJem5JNDZ3Q1gwdjBubXlyOE5Ic1FhVTR1S3hZcy1nR2hibER5dGxuOG0xS3h0V0plVUtFYVFPS2Jn?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-23T07:00:00+00:00", "published_display": "23 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mental health firm Neuronetics doubles revenue as clinics surge, new CEO named", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNc2RfSGtqbTRTX2NTaHVHQTFaOV9TYzVMTDI3QjNlNXdnekRhYlE1NlJCT3c3WVJwRG9NOWJGTE9FVnRXeWUxcWtSVHpMX1RWVndrc002ZWFfQ1kxMFM1cDJHUUJOSFNZZnpRQ0ctdWJpS0F6OFpHaUNFdXFXZ1UwZHdlZmlsZG9tNU1neGFHSmR5YWwwTUkzTmlxZXN6YzlmZnF6S3VhNUxCamZ5eVBSNm1wdHcyeUhTbFRqbnZoYw?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NEURONETICS ($STIM) Releases Q4 2025 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxPTU52WEFkeGpGQ0pNcklqelh5YnBuN2dhVWh1WVRyWGhHZnZmMmJTeTNObVRWeUl2UG5pY1hQZGlWZWdUVVFxNmtvWkotQWRQdG5BR0xuUTNTVnRJazRPak1VaHNjbzEtZExabm93RVRPSVJpSzEtdFR6NHgySTNkYU5WaVBoc09iOXpKLQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "What Does Jorey Chernett's Recent Buying Spree Signal for Neuronetics (STIM)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOUm52VjdBN1F5eFpycExKczdrdUpGNXFmb1NIT21sMFA1RDBUUkxwVHdfRFpOVTY4TXJfMGE2cGtObl9SOGh1RTEweV9lUUV0VUt4bk10TTRNQXBmSzU2NUphcVVSRloycHJXQ2RGQmNHd0JMUEJHWF8xazVoOWtrc0tIQWlrZzFrV2c1aGRUcVdBM20waGJBWE15LXBKczlDd0J1eXQwTlNZTl9qQlE?oc=5", "source_name": "Kavout | AI", "published_at": "2026-07-15T23:09:01+00:00", "published_display": "15 Jul 2026 23:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Buying: Jorey Chernett Acquires 35,000 Shares of Neuronetics Inc (STIM)", "summary": "Jorey Chernett, a 10% owner of Neuronetics Inc (STIM), purchased 35,000 shares on July 14, 2026, increasing his total holdings to 10,588,988 shares. This acquisition is part of a trend where Chernett has bought over 3.6 million shares in the past year with no sales. Neuronetics I", "url": "https://www.gurufocus.com/news/8960617/insider-buying-jorey-chernett-acquires-35000-shares-of-neuronetics-inc-stim", "source_name": "GuruFocus", "published_at": "2026-07-15T16:19:03", "published_display": "15 Jul 2026 16:19", "sentiment": "positive", "sentiment_pct": 72, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics (NASDAQ: STIM) major holder buys 35,000 common shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNN1o1MGZFelBTQVc2TEF6QUFjaGFHbEUxMFIxeHh3RVQ2cGtsM1pJOEN1M2oyWEtNdGNtUTRJWF9hLWVPR1BNNHB1akJBbGpPYVFiLTlneHpsWE5kUU54ZDFfOWdDa1lxdVlEWlcwWi16SWFrdm02SnJDRnRiU2E4RlFIb2k3cmFlVDVza0wyblpPQ2cyUVdsVENIZnRodEV6dWFOS3d5ZkZCVExqbHc?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T13:33:48+00:00", "published_display": "15 Jul 2026 13:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Neuronetics Inc For: 15 July By Investing.com", "summary": "This article from Investing.com announces the filing of Form 4 for Neuronetics Inc. on July 15. The brief piece includes the stock symbol STIM and notes a 3.95% increase for the company. It serves as a concise update on a regulatory filing for Neuronetics.", "url": "https://ca.investing.com/news/stock-market-news/form-4-neuronetics-inc-for-15-july-93CH-4735508", "source_name": "Investing.com Canada", "published_at": "2026-07-15T13:19:03", "published_display": "15 Jul 2026 13:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics: Jorey Chernett acquires $62,300 common stock", "summary": "Jorey Chernett, a 10% owner of Neuronetics, Inc. (NASDAQ:STIM), acquired 35,000 shares of common stock for $62,300 on July 14, 2026. This transaction increased his direct holdings to 10,588,988 shares. Despite a recent 15% stock return, InvestingPro analysis indicates the shares ", "url": "https://www.investing.com/news/insider-trading-news/neuronetics-jorey-chernett-acquires-62300-common-stock-93CH-4793564", "source_name": "Investing.com", "published_at": "2026-07-15T13:19:03", "published_display": "15 Jul 2026 13:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics (STIM) to Present at B. Riley Mind, Muscle & Vision Summit", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQX1RERE1LOFFuTXBoRWxMa2tPSGN2QTlIVFdJUEJUVzFIbGRzUEFsRHJzSGhad3g1UFN1TU0tR3NBSms3THIwRmV3eHItWmh3MG8xa3FNQ0V3SG5qQy1SallONXNvU2VCaGhNMVVBcFdnaUpoR3ZjYng3TXNCbVdvb1NvZHlsZ3ZjcFdkT2pCZmZYMDJ4Ty02cg?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:08:05+00:00", "published_display": "14 Jul 2026 18:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics (STIM) EVP Cory Anderson reports PRSU awards tied to cash metrics", "summary": "Neuronetics' EVP & Gen. Manager, Greenbrook, Cory Anderson, filed an initial statement of beneficial ownership, revealing holdings of common stock and performance restricted stock units (PRSUs). These PRSUs, totaling up to 15,000 and 18,335 shares, vest between December 2026 and ", "url": "https://www.stocktitan.net/sec-filings/STIM/form-3-neuronetics-inc-initial-statement-of-beneficial-ownership-fe3a93f52626.html", "source_name": "Stock Titan", "published_at": "2026-07-13T20:41:55", "published_display": "13 Jul 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026", "summary": "Neuronetics, Inc. announced its management will participate in a panel discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026, in Boston. The panel, titled \"Commercializing the Next Wave of Novel Neuropsychiatric Drugs,\" will include Compass Pathways. Ne", "url": "https://www.manilatimes.net/2026/07/06/tmt-newswire/globenewswire/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026/2379046/amp", "source_name": "The Manila Times", "published_at": "2026-07-06T12:41:53", "published_display": "06 Jul 2026 12:41", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics to Participate at B. Riley Securities\u2019 Mind, Muscle & Vision Summit", "summary": "Neuronetics, Inc. will participate in the B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026, in Boston. The company will be part of a panel discussion focused on \"Commercializing the Next Wave of Novel Neuropsychiatric Drugs\" and will also hold one-on-one meeting", "url": "https://www.quiverquant.com/news/Neuronetics+to+Participate+at+B.+Riley+Securities%E2%80%99+Mind,+Muscle+&+Vision+Summit", "source_name": "Quiver Quantitative", "published_at": "2026-07-06T12:41:49", "published_display": "06 Jul 2026 12:41", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics joins neuropsychiatry panel at B. Riley investor summit", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNMkwwOTJfTDl5MlV5VjhpUnJYUExHOEFpd29RZHEyRnJEeUptLVBXb0ZpSUZkRndXVm14VWR1Q0ZJNTZaQVdWam9WeFR1UkF6eGMyLXlVSmxlZnd5ZGpZR2w5N2duZkZ2TkJfV2k1aGE3aVYzMDZJQnRQRExzVV90YmNqUno5LUtpamgyYjlCS1JPcmtvVnlTN19xcEh2OFEwV0U4aU9VM0otSXNWNzZCbEVXZ1Y?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics stock leans on its core therapy platform.", "summary": "Neuronetics (NASDAQ:STIM) stock continues to focus on its medical-device business, with investors looking at the company's NeuroStar therapy platform and its commercial rollout. The company's core product, NeuroStar Advanced Therapy, is a noninvasive treatment system for depressi", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/neuronetics-stock-leans-on-its-core-therapy-platform/69682101", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-03T17:39:17", "published_display": "03 Jul 2026 17:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STIM News | NEURONETICS INC (NASDAQ:STIM)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTFBWV0g0SDhSV1p5SHNzbmNZTUJuX0dBQVBDa2ZLNmowVUVXUk9QcEtqT1p4TGVzMEpKRjVpQzhSODRoSWR6SFliSGFqS0dhdTdrVEZsNExlRHl5MUE?oc=5", "source_name": "ChartMill", "published_at": "2026-07-03T00:06:54+00:00", "published_display": "03 Jul 2026 00:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics, Inc.(NasdaqGM: STIM) dropped from Russell 2000 Growth Benchmark", "summary": "Neuronetics, Inc. (NasdaqGM: STIM) has been removed from the Russell 2000 Growth Benchmark and several other Russell indices, including the Russell 2000, Russell 2500, Russell 3000, and Russell 3000E indices and their growth benchmarks. This change follows a series of recent lead", "url": "https://www.marketscreener.com/news/neuronetics-inc-nasdaqgm-stim-dropped-from-russell-2000-growth-benchmark-ce7f5fdcd981f624", "source_name": "marketscreener.com", "published_at": "2026-07-01T11:12:09", "published_display": "01 Jul 2026 11:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Neuronetics, Inc. \u2013 NASDAQ:STIM", "summary": "This page provides financial information for Neuronetics, Inc. (NASDAQ: STIM), specifically focusing on its forward price-to-sales ratio. It appears to be a financial data page from TradingView, offering an overview of the company's financials for investors and analysts. Despite ", "url": "https://www.tradingview.com/symbols/NASDAQ-STIM/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T20:10:58", "published_display": "28 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Neuronetics, Inc. \u2013 NASDAQ:STIM", "summary": "This article provides financial information for Neuronetics, Inc. (NASDAQ: STIM), specifically its enterprise value to EBITDA forward. It indicates data is sourced from ICE Data Services, FactSet, American Bankers Association, and Quartr for SEC filings.", "url": "https://www.tradingview.com/symbols/NASDAQ-STIM/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T18:39:43", "published_display": "26 Jun 2026 18:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics Inc (STIM) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "Neuronetics Inc (STIM) currently has a price momentum score of 6.93, ranking 131st in its industry, with its stock trading between resistance at $1.66 and support at $1.09, suggesting suitability for range-bound swing trading. Technical indicators show a mixed signal with 2 buy, ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-stim/technical", "source_name": "TradingKey", "published_at": "2026-06-26T17:10:44", "published_display": "26 Jun 2026 17:10", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics, Inc. Actuals & Estimates (NASDAQ:STIM)", "summary": "This article provides an overview of Neuronetics, Inc. (NASDAQ: STIM) stock, including its current price, market capitalization, volatility, and analyst forecasts. It also details financial data such as past earnings, revenue, net income, and upcoming earnings report dates. The c", "url": "https://www.tradingview.com/symbols/NASDAQ-STIM/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T16:39:32", "published_display": "26 Jun 2026 16:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Neuronetics, Inc. \u2013 NASDAQ:STIM", "summary": "This article provides financial information for Neuronetics, Inc. (NASDAQ: STIM), specifically its forward price-to-earnings ratio. It indicates that the market was closed at the time of publication and no trades were recorded. The content is presented within the context of Tradi", "url": "https://www.tradingview.com/symbols/NASDAQ-STIM/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T03:10:03", "published_display": "26 Jun 2026 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STIM Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for Neuronetics, Inc. (STIM) stock, based on analysis from three different analysts. It includes current stock performance metrics, historical price data, financial statements, and an earnings report schedule. The article also pro", "url": "https://www.tradingview.com/symbols/NASDAQ-STIM/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T00:08:58", "published_display": "26 Jun 2026 00:08", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 8K Neuronetics Inc For: 23 June By Investing.com", "summary": "This article announces that Neuronetics Inc. filed a Form 8K on June 23. The Form 8K is a crucial SEC filing that companies use to announce unscheduled material events or corporate changes that are important to shareholders and the SEC. Further details about the content of the fi", "url": "https://ng.investing.com/news/stock-market-news/form-8k-neuronetics-inc-for-23-june-93CH-2570907", "source_name": "Investing.com Nigeria", "published_at": "2026-06-24T15:40:51", "published_display": "24 Jun 2026 15:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cory Anderson named EVP, GM of Greenbrook at Neuronetics (NASDAQ: STIM)", "summary": "Neuronetics, Inc. has promoted Cory Anderson to Executive Vice President, General Manager of Greenbrook, effective July 1, 2026. Anderson, who previously served as Senior Vice President, Chief Technology Officer, will receive an annual base salary of $425,000 and a target discret", "url": "https://www.stocktitan.net/sec-filings/STIM/8-k-neuronetics-inc-reports-material-event-6b0ba4128523.html", "source_name": "Stock Titan", "published_at": "2026-06-23T20:10:13", "published_display": "23 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics Inc (STIM) Institutional Confidence", "summary": "The article reports on Neuronetics Inc's (STIM) institutional confidence score, which is currently 5.00, placing it 109th out of 203 in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion has increased by 11.24% quarter-over-quarter, reaching 6", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-stim/sentiment", "source_name": "TradingKey", "published_at": "2026-06-19T01:40:33", "published_display": "19 Jun 2026 01:40", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics Inc (STIM) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Neuronetics Inc (STIM) currently holds an earnings forecast score of 8.00, placing it 66th in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $7.00, with a consensus \"Buy\" rating based on 3 analysts. The company's expected revenue for th", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-stim/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T14:09:11", "published_display": "18 Jun 2026 14:09", "sentiment": "positive", "sentiment_pct": 76, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics Inc (STIM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for Neuronetics Inc (STIM) by business segments and regional contributions. The data, updated on April 6th, shows that Clinic revenue and Treatment sessions are the largest business segments, while the United States accounts for the vast ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-stim/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T05:40:10", "published_display": "18 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics Inc (STIM) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis for Neuronetics Inc (STIM), indicating its current valuation score is 8.49, ranking it 94 out of 204 in the Healthcare Equipment & Supplies industry. It highlights the company's P/E ratio of -2.24, noting its position relative to recent ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-stim/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-18T01:09:11", "published_display": "18 Jun 2026 01:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics Inc (STIM) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Neuronetics Inc (STIM), outlining its major shareholders and institutional holdings as of recent reporting periods. It identifies top shareholders such as Madryn Asset Management, LP, Chernett (Jorey), and Parian Ultreia LP, and c", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-stim/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T00:40:11", "published_display": "18 Jun 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics Inc (STIM) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Neuronetics Inc's (STIM) dividend and stock split history. It notes that no dividends have been distributed in the past five years and there is no data available for stock splits. The page also includes current stock performance metrics and ma", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-stim/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T00:40:11", "published_display": "18 Jun 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Madryn funds (NASDAQ: STIM) reallocate 72,500 Neuronetics RSU shares", "summary": "Madryn Asset Management's affiliated funds have reallocated 72,500 Neuronetics (NASDAQ: STIM) RSU shares. These internal transfers, reported in an SEC Form 4 filing, involved shares granted as director compensation to Avinash Amin and moved among Madryn Health Partners II, Madryn", "url": "https://www.stocktitan.net/sec-filings/STIM/form-4-neuronetics-inc-insider-trading-activity-b2042bc08b67.html", "source_name": "Stock Titan", "published_at": "2026-06-17T20:39:24", "published_display": "17 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics (NASDAQ: STIM) director reallocates 42,500 shares to Madryn funds", "summary": "Neuronetics (NASDAQ: STIM) director Avinash Amin reallocated 42,500 shares of common stock across three affiliated Madryn funds (Madryn Health Partners II, LP, Madryn Health Partners II (Cayman Master), LP, and Madryn Select Opportunities, LP) on June 15, 2026. These J-code trans", "url": "https://www.stocktitan.net/sec-filings/STIM/form-4-neuronetics-inc-insider-trading-activity-8e9bb69fc5aa.html", "source_name": "Stock Titan", "published_at": "2026-06-17T20:39:24", "published_display": "17 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STIM (NASDAQ) affiliate files to sell 42,164 vested shares via Fidelity", "summary": "An affiliate of Neuronetics, Inc. (NASDAQ: STIM) has filed a Form 144 notice to sell 42,164 shares of common stock stemming from restricted stock vesting. The proposed transaction is intended for June 8, 2026, and lists Fidelity Brokerage Services LLC as the broker-dealer. The fi", "url": "https://www.stocktitan.net/sec-filings/STIM/144-neuronetics-inc-sec-filing-c41f32a0d015.html", "source_name": "Stock Titan", "published_at": "2026-06-08T22:38:42", "published_display": "08 Jun 2026 22:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics Appoints Robert Greene as Senior Vice President Sales", "summary": "Neuronetics, Inc. (NASDAQ: STIM) has announced the appointment of Robert Greene as Senior Vice President Sales, effective June 1, 2026. Greene brings extensive experience in commercial strategy and sales leadership within the healthcare and medical technology sectors. In connecti", "url": "https://www.manilatimes.net/2026/06/03/tmt-newswire/globenewswire/neuronetics-appoints-robert-greene-as-senior-vice-president-sales/2357331", "source_name": "The Manila Times", "published_at": "2026-06-03T07:40:31", "published_display": "03 Jun 2026 07:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics, Inc. Announces Appointment of Robert Greene to Senior Vice President Sales, Effective June 1, 2026", "summary": "Neuronetics, Inc. has announced the appointment of Robert Greene as its Senior Vice President Sales, effective June 1, 2026. Greene brings extensive experience in leading commercial strategy and sales organizations within the healthcare and medical technology sectors, including c", "url": "https://www.marketscreener.com/news/neuronetics-inc-announces-appointment-of-robert-greene-to-senior-vice-president-sales-effective-j-ce7f5ddfd88ff622", "source_name": "www.marketscreener.com", "published_at": "2026-06-03T06:40:55", "published_display": "03 Jun 2026 06:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New Neuronetics sales chief gets 200,000-share stock grant", "summary": "Neuronetics (NASDAQ: STIM) has appointed Robert Greene as its Senior Vice President of Sales, effective June 1, 2026. In connection with his hiring, Greene received an inducement grant of 200,000 restricted stock units (RSUs), vesting in four equal annual installments. This appoi", "url": "https://www.stocktitan.net/news/STIM/neuronetics-appoints-robert-greene-as-senior-vice-president-h9ikiqhbr4un.html", "source_name": "Stock Titan", "published_at": "2026-06-02T20:39:48", "published_display": "02 Jun 2026 20:39", "sentiment": "positive", "sentiment_pct": 69, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/neuronetics-highlights-continued-advancements-tms-123200467.html", "source_name": "GlobeNewswire", "published_at": "2026-06-02T12:32:00+00:00", "published_display": "02 Jun 2026 12:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STIM - Neuronetics Inc Stock Price and Quote", "summary": "", "url": "https://news.google.com/rss/articles/CBMiRkFVX3lxTE5UckMxYm11eENDaEIwZUpKME5vUlFZaTZOSXBLNnp3MWhnbXA5RXI1VHlzbEhRSTNRc1VrWG1ZN2gtNktFeEE?oc=5", "source_name": "Finviz", "published_at": "2026-05-27T09:08:06+00:00", "published_display": "27 May 2026 09:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/neuronetics-ant-neuro-announce-strategic-123200783.html", "source_name": "GlobeNewswire", "published_at": "2026-05-14T12:32:00+00:00", "published_display": "14 May 2026 12:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics Insider Bought Shares Worth $636,500, According to a Recent SEC Filing", "summary": "", "url": "https://finance.yahoo.com/news/neuronetics-insider-bought-shares-worth-123700257.html", "source_name": "MT Newswires", "published_at": "2026-05-13T12:37:00+00:00", "published_display": "13 May 2026 12:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics (STIM) Margin Compression Reinforces Bearish Clinic Mix Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/f14e3ff5-d0a2-334d-9b3d-981c4b206675/neuronetics-q1-earnings-call.html", "source_name": "MarketBeat", "published_at": "2026-05-05T21:07:06+00:00", "published_display": "05 May 2026 21:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/61767052-afa9-3de5-9860-759b289c09eb/neuronetics%2C-inc.-q1-2026.html", "source_name": "Moby", "published_at": "2026-05-05T20:55:23+00:00", "published_display": "05 May 2026 20:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics STIM Stock Jumps As Activist Pressure Meets Growth Tailwinds", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE9FVGlmRXpJc2E3VVNnU3VzdlRRZjRUWC1JcW00MWM4UThKZE94RG9KVGg4SWRpTnRpbjJEOGlYcHBFWlZUSTBKLWFmc3NuRW5RWTBTNDBVUTd3M2E3QlFYWDN4WWZibldzT1RINXpKVVFqSGN2TUJB?oc=5", "source_name": "StocksToTrade", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NEURONETICS ($STIM) Releases Q1 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxQUVVmMV9VTGl4eDRCclFYYUJ4cTdLM0pNd3BlRmhhN2Z1MDQ0T1BuajBsbGw3anpWSFZlcmxONDdLLWZfb1BIelpOMGFPN0tiX2FZU0VFeVZtNjZSMk5JcUlvUzhzZWtiS1pXeXdxQ2F6QkdIanhFZnFrWWMtU29RcUg4TFNWN1BwcEFXaw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQRmVsckdlQ09JYk9aZVNuaFF5VXV3QVBGRXpaOE42MmluMVRSQkc5NlJnMmxvblQtME5tbmpkNUkzeDh4OUZLUS1USXhUN0M3Z2JudXdINGFBWlVPWXBLTm41VDR6bWRCU0s5ckVEWkp6TWlwbk55RGpFUmFIaTFnam1fOEtmbVlnZzlZS2Jpc0VoQ1R6UUZxVExNQW9oVnRudXow?oc=5", "source_name": "Market source", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Neuronetics (STIM) Investment Story Is Evolving With A Reset Price Target", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQd1ZsdVRXWVZtZEMwQ0JLcVlSX0xXRWVDSzlPTVgxeURmQXpLQXBCdTc5dmVwZ1g3MmliVkNVVS16RlhVTjI0UW13ZEhRSGk5QW5wbjd2TC1hTHRrcmotRGhCcHpodmZHSlFBVzF4UGJCTDFPYkx3LTdldnlpZ002bUFHVVBPdkNWM05qWGpLSFlZSnY2bE9zNDFqNlA4eERPbEg2dXp3WVA4aGM?oc=5", "source_name": "Market source", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New Neuronetics hires get stock awards that vest over up to 4 years", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPZDRnQnpubzhFZmV1ZWRhQVYzVGx0U3hpYlFmZUs3WGl2ZTJhLUVHWnZmaGRZQVJBZ2RaM0w5bXMxVFNSb3h0c3JkOHRiRS1WUHJaWDF1T25BVkRQclVkbUpMaF9LNU5COUpldjhnQWltVHhfZHpxeGx2NzRwbnZIZm1pQlllUFBYNW5YQjZ5SktCam02VDNfcmRuWW1EZEx3NldWaENPTGwyby02WVVnV2JwSWpyRTVPSnRXMXhJZw?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Neuronetics (STIM) Investment Story Is Reset As Analysts Rework Valuation Assumptions", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOSnNHNkZmQVJ0YndJaUV5ekhqYzA1YmNqaFAyRTZiY1kxRXZXcVBxX1pZd2c5RXZJbUMtWFJKM2tBVzh5aThnRHlPdjdrUmtMN3RQandSaFZXc3lDQzJwMlJNZUw2TkZ0cUs0QVJJTU8tdTRaTGEwN29hWGxWb2JPc3VqMXh4ZUg3ZDZUUG1SZEhhaGxtdWRKM2VnZmQ1YmRmdW50OW5Ccw?oc=5", "source_name": "Market source", "published_at": "2026-04-18T07:00:00+00:00", "published_display": "18 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics says board is open to shareholder talks on valuation", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQWkdreUtQdTRVVkZrUTZicFZPRVBRc2dzMVFsdHhZUXJvLTVOYUhoYVIzR3A5cjJ5aENWNlF2aVhQRndCb2N3OTIyNy1oMmVHOVM3NkRreGRxZG5leGxuellVNHB1REZkai1qa2lwODNseWNoc3VlUDZNWUFCQ2ZNbGYtYzViRFRqcTIxa1NTN3NhWndfT1IwWUpMbEREZUJBTzdwYVE0YWJNRi1IOFE?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics sticks with 2026 outlook as finance chief plans exit", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNeU0xcHhwdmZ4MkIwdWNRakJWOE5iTDNxeEJKOFRPMU5tZWdFcUtUM085TndvX3RZRXN3bE1WYmc1RGp6NzlrNl9lU3FnNF9PVTd2T3BZYS1sTEVkdkRlNGZoMDBzMmdsVW5keGp5UTNuXzVab1RtOXB3WUpHdUp6LU5tUzlhZWVXZmN3MEdINVFxTlh3Rmw3d3VZZjlsaTZaUmc?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-06T07:00:00+00:00", "published_display": "06 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Neuronetics (STIM) Story Is Shifting As Analysts Rework Valuation Assumptions", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNSE1PT3VSVTRHZTFQUV93NzhnaHdaSEdnRFJGZDVFeUdTQ3ZIYW1jYm91VU5zN2ktQlZTTm93YnBBaWFCSm52TFBaNzd6ZnRjQWxRRU4ySEI4VGNtek5obEpmOTBVclloRHNBcWNZcWVyOEMxOHAyeUVoRUZsYnVrMUZrNmpSaEpUdDlyOEMxUldxazA4WWpRVGEwLVIzUVR0V0NMOUlpa04?oc=5", "source_name": "Market source", "published_at": "2026-04-03T07:00:00+00:00", "published_display": "03 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuronetics: Highly Speculative, But Revenue Growth Could Drive The Stock Higher (STIM)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSGtJMHdPUjVtb1h2QlBscUdQaDJqR0QtM0J1VHF2Z0h4clhqcW4yM01GRk5weWdnRlhvenN3UDFtblVFTDlCWDNLQ0FiYXJDaXg4dHFVc1JSaGxqakxIek9LelNXSmg5ZTUtMHAybTdFMmhsR3c2MTc4eVhWOUNUV2ZJem5JNDZ3Q1gwdjBubXlyOE5Ic1FhVTR1S3hZcy1nR2hibER5dGxuOG0xS3h0V0plVUtFYVFPS2Jn?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-23T07:00:00+00:00", "published_display": "23 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mental health firm Neuronetics doubles revenue as clinics surge, new CEO named", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNc2RfSGtqbTRTX2NTaHVHQTFaOV9TYzVMTDI3QjNlNXdnekRhYlE1NlJCT3c3WVJwRG9NOWJGTE9FVnRXeWUxcWtSVHpMX1RWVndrc002ZWFfQ1kxMFM1cDJHUUJOSFNZZnpRQ0ctdWJpS0F6OFpHaUNFdXFXZ1UwZHdlZmlsZG9tNU1neGFHSmR5YWwwTUkzTmlxZXN6YzlmZnF6S3VhNUxCamZ5eVBSNm1wdHcyeUhTbFRqbnZoYw?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NEURONETICS ($STIM) Releases Q4 2025 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxPTU52WEFkeGpGQ0pNcklqelh5YnBuN2dhVWh1WVRyWGhHZnZmMmJTeTNObVRWeUl2UG5pY1hQZGlWZWdUVVFxNmtvWkotQWRQdG5BR0xuUTNTVnRJazRPak1VaHNjbzEtZExabm93RVRPSVJpSzEtdFR6NHgySTNkYU5WaVBoc09iOXpKLQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 106, "total_relevant": 69, "sentiment_summary": {"positive": 14, "negative": 2, "neutral": 53, "score": 54, "total": 69, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 79, "events": [{"event": "general", "label": "Market update", "weight": 19.8, "count": 36}, {"event": "earnings", "label": "Earnings", "weight": 12.59, "count": 25}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.1, "count": 2}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 14, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 1.76, "latest_week": "2026-07-10", "one_week_move": 24.8, "four_week_move": 32.3, "twelve_week_move": 23.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.499603, "market_dynamics_buy_signal": true, "relative_strength": -29.03605, "fair_value_gap": -24.8, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 51.761, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+24.8% over one week, +32.3% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 62, "badges": ["Market Dynamics buy signal", "Value support"], "opportunities": ["Market Dynamics is showing a buy signal in the latest weekly context.", "Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 12}, {"label": "Market source", "count": 12}, {"label": "TradingKey", "count": 7}, {"label": "TradingView", "count": 5}, {"label": "Quiver Quantitative", "count": 3}, {"label": "The Manila Times", "count": 2}, {"label": "GlobeNewswire", "count": 2}, {"label": "Kavout | AI", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 58}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 36}, {"label": "Earnings", "count": 25}, {"label": "Balance sheet", "count": 2}, {"label": "Analyst action", "count": 2}, {"label": "Deals and strategy", "count": 1}, {"label": "Regulatory and legal", "count": 1}, {"label": "Capital return", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "79/100 classification confidence."}, {"label": "Company focus", "value": "58", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+24.8% over one week, +32.3% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "What Does Jorey Chernett's Recent Buying Spree Signal for Neuronetics (STIM)"}], "updated_at": "2026-07-16T11:54:28.047269+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}